Neo-adjuvant tislelizumab combined with lenvatinib treatment for resectable, recurrent hepatocellular carcinoma.

被引：1
|
作者：
Ming, Kuang [1 ]
Xie, Wenxuan [1 ]
Chen, Jingying [1 ]
Chen, Shuling [1 ]
Wang, Yuanqi [1 ]
Shen, Shunli [1 ]
Peng, Sui [1 ]
机构：
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
261-3278; 613-4678-146-1332; 261-492-199-2823; 261-492-2769; 261-492-5651-5655; 283-424-425; 613-135-244-3829-325; 8; 5; 3; 2; 2424; 28;
D O I：
10.1200/JCO.2024.42.3_suppl.517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [31] Transplantation and adjuvant chemotherapy for hepatocellular carcinoma.
    Villanueva, MJ
    Navarro, F
    Sánchez, A
    Provencio, M
    Bonilla, F
    España, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [32] Neo-adjuvant FOLFIRINOX in borderline-resectable/locally advanced pancreatic adenocarcinoma
    Temraz, S.
    Albonji, W.
    Charafeddine, M.
    Farhat, Z.
    Mukherji, D.
    Shamseddine, A.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 95 - 95
  • [33] Neoadjuvant tislelizumab for resectable recurrent hepatocellular carcinoma: A non-randomized control, phase II trial (TALENT)
    Chen, S.
    Wang, Y.
    Xie, W.
    Shen, S.
    Peng, S.
    Kuang, M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S867 - S867
  • [34] Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
    Crook, Christiana J.
    Li, Daneng
    [J]. CURRENT ONCOLOGY REPORTS, 2023, 25 (10) : 1191 - 1201
  • [35] Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma
    Christiana J. Crook
    Daneng Li
    [J]. Current Oncology Reports, 2023, 25 : 1191 - 1201
  • [36] A retrospective study on the efficacy and safety of sorafenib or lenvatinib combined with sintilimab in patients with advanced hepatocellular carcinoma.
    Zeng, Zhen
    Zhang, Linzhi
    Wu, Tong
    Cheng, Jiamin
    Chen, Yan
    Lu, Yinying
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Benefits of measuring urinary protein/creatinine ratio in lenvatinib treatment for unresectable hepatocellular carcinoma.
    Morishita, Koki
    Suzuki, Hidetaka
    Tauchi, Junko
    Takeno, Misaki K.
    Yamaguchi, Shota
    Inoue, Kanae
    Taira, Tomonao
    Eguchi, Hiroki
    Okumura, Kei
    Shibuki, Taro
    Satake, Tomoyuki
    Watanabe, Kazuo
    Imaoka, Hiroshi
    Sasaki, Mitsuhito
    Mitsunaga, Shuichi
    Kawasaki, Toshikatsu
    Ikeda, Masafumi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 529 - 529
  • [38] Living Donor Liver Transplantation for Hepatocellular Carcinoma: The Impact of Neo-Adjuvant Treatments on the Long Term Results
    Di Sandro, Stefano
    Giacomoni, Alessandro
    Slim, Abdallah
    Lauterio, Andrea
    Mangoni, Iacopo
    Mihaylov, Plamen
    Pirotta, Vincenzo
    Aseni, Paolo
    De Carlis, Luciano
    [J]. HEPATO-GASTROENTEROLOGY, 2012, 59 (114) : 505 - 510
  • [39] LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: THE IMPACT OF NEO-ADJUVANT TREATMENTS ON THE LONG TERM RESULTS
    Slim, Abdallah
    Di Sandro, Stefano
    Lauterio, Andrea
    Giacomoni, Alessandro
    Mangoni, Iacopo
    Mihaylov, Plamen
    Tripepi, Matteo
    Poli, Cinzia
    Lamperti, Luca
    Cusumano, Caterina
    De Carlis, Luciano
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 167 - 167
  • [40] Living Donor Liver Transplantation for Hepatocellular Carcinoma: The Impact of Neo-Adjuvant Treatments on the Long Term Results
    Di Sandro, Stefano
    Mangoni, Iacopo
    Slim, Abdallah
    Giacomoni, Alessandro
    Lauterio, Andrea
    Mihaylov, Plamen
    Pirotta, Vincenzo
    Aseni, Paolo
    De Carlis, Luciano
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S268 - S268
12345